Skip to main content

[Whitepaper] Benefits and Challenges of Medicare’s Enhancing Oncology Model

Benefits and Challenges of Medicare’s Enhancing Oncology Model

During a Carevive-hosted webinar on August 10, 2022, Carevive co-founder and vice-chairman Madelyn Herzfeld facilitated a frank discussion with a multidisciplinary panel of oncology care providers and online participants about the benefits and challenges of participating in enhancing oncology model.

The Enhancing Oncology Model (EOM) introduced by the Centers for Medicare & Medicaid Services (CMS) Innovation Center on June 27, 2022, is a voluntary cancer-care reimbursement model set to take effect on July 1, 2023. Oncology group practices wishing to participate in EOM must respond to the CMS request for non-binding applications by September 30, 2022. Thus, a sense of urgency exists among cancer centers across the United States as they deliberate whether participation in EOM is right for their institutions, their employees, and the patients they serve.

Submit the below form to download our latest whitepaper: “Benefits and Challenges of Medicare’s Enhancing Oncology Model“.

"The OCM allowed us that stepped approach to be able to bring this into a sustainable model for all of our patients. OCM provided the support we needed to develop a psycho-oncology program.”

Gabrielle Rocque, MD, MSPHO’Neal Comprehensive Cancer Center at UAB